|
HS Code |
678140 |
| Chemical Name | 4-Bromo-1H-Imidazole |
| Cas Number | 934-34-9 |
| Molecular Formula | C3H3BrN2 |
| Molecular Weight | 162.98 |
| Appearance | White to off-white crystalline powder |
| Melting Point | 139-142°C |
| Purity | Typically ≥98% |
| Solubility | Soluble in water and organic solvents |
| Smiles | C1=CN=CN1Br |
| Inchi | InChI=1S/C3H3BrN2/c4-3-1-5-2-6-3/h1-2H,(H,5,6) |
| Storage Conditions | Store at room temperature, away from light and moisture |
As an accredited 4-Bromo-1H-Imidazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle containing 25 grams of 4-Bromo-1H-Imidazole, sealed with a screw cap and labeled with hazard and product information. |
| Shipping | **Shipping Description:** 4-Bromo-1H-Imidazole is shipped in tightly sealed, chemically compatible containers to prevent moisture or air exposure. Packages are clearly labeled with hazard and handling information, complying with local regulations for hazardous chemicals. Protective packaging ensures safe transportation, minimizing the risk of spills or contamination during transit. Suitable for ground or air shipment. |
| Storage | 4-Bromo-1H-Imidazole should be stored in a tightly sealed container in a cool, dry, and well-ventilated area away from incompatible substances such as strong oxidizers. The storage area should be protected from light and moisture to prevent decomposition. Ensure that the chemical is clearly labeled, and access is restricted to trained personnel equipped with appropriate safety measures. |
Applications of 4-Bromo-1H-Imidazole in Industrial ManufacturingAs a direct manufacturer of 4-Bromo-1H-Imidazole, we supply this specialty imidazole derivative for several advanced synthesis applications across life sciences, electronics, and chemical industries. The following industrial sectors represent key downstream deployment scenarios, with technical and compliance details for formulation and process integration. 1. Pharmaceutical Active Ingredient Intermediates4-Bromo-1H-Imidazole functions as an essential heterocyclic intermediate in the syntheses of drug candidate molecules, particularly for imidazole-based antifungal, antiviral, and anticancer compounds. This raw material forms a core building block through bromination, enabling nucleophilic substitutions and coupling reactions to attach custom functional groups. Our technical team collaborates with formulators to match GMP and ICH Q7 compliance, traceability, and impurity profile requirements in final APIs and research compounds. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Synthesis and Crop Protection ProductsThis intermediate supports the synthesis of azole-based crop protection actives, such as fungicides and seed treatments. Its imidazole core permits specific halogenation and cross-coupling steps, yielding molecules with targeted bioactivity against plant pathogens. Downstream partners integrate this raw material into multi-stage synthesis lines, aligned with food safety and environmental regulations for crop chemical actives. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. High-performance Electronic Materials: OLED and Conductive PolymersElectronic material producers apply this imidazole derivative in the preparation of heteroaromatic monomers and ligands, essential for organic light-emitting diode (OLED) layers, hole transport materials, and conductive polymers. Its unique halogen functionality increases compatibility for metal complexation and functionalization, meeting electronics industry purity levels and EHS compliance. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Specialty Chemical Synthesis for Catalysis and Ligand Design4-Bromo-1H-Imidazole serves as a critical starting material for custom ligand and catalyst development, especially for transition metal-catalyzed processes in fine chemicals and pharmaceutical manufacturing. Its halogen position enables rapid modification and complexation with palladium, nickel, or copper, supporting elevated selectivity and turnover number in catalytic applications. Downstream partners require trace impurities control, material safety compliance, and reliable lot-to-lot performance for R&D and scale production. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 4-Bromo-1H-Imidazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Producing 4-Bromo-1H-Imidazole day in and day out, we keep a close eye on the factors that set each lot apart. Handling the synthesis ourselves offers us a full view into the subtle differences batch to batch. We start with high-grade starting materials and pay close attention to process controls at every stage. This gives us the stability that research chemists look for, with minimal byproducts and consistent reactivity. In the chemical sector, repeatability tells its own story: reactions run true, downstream partners save time, and waste shrinks to a minimum. Over years of meeting tight deadlines for pharmaceuticals and advanced materials firms, we’ve seen that dependability earns its place above every sales pitch and glossy promise.
Our 4-Bromo-1H-Imidazole comes as a nearly white crystalline solid, with a typical assay above 98%. Melt point checks serve as our daily checkpoint; we watch for a smooth drop through the expected range (165-170°C in most runs), flagging any drift long before it affects our customers. Trace moisture can invite trouble in moisture-sensitive reactions, so we keep Karl Fischer titration as part of our outgoing checks. Customers have let us know when particle size gets too coarse or too fine for their set-ups, and we’ve adjusted milling steps based on real lab feedback, not just industry averages. For those heading into scale-up, it’s these small details—which only matter because we’ve run into the issues ourselves—that separate a basic product from a partner that smooths the path from test tube to ton scale.
We find 4-Bromo-1H-Imidazole walking into more workflows every year. Most clients use it as a starting scaffold; the bromine atom at the 4-position opens up straightforward routes to substitution or cross-coupling. In medicinal chemistry, that means more tailored molecules, quicker SAR cycles, or easy modifications for patents. Organometallic chemists rely on its clean reactivity during Suzuki, Buchwald-Hartwig, or other Pd-catalyzed couplings. We’ve also seen it adopted in materials programs, such as organic electronics where selective functionalization can shift properties by orders of magnitude. Those who handle real-world scale-up have told us that reliable melting, solubility, and minimal tar formation matter as much as any purity figure on paper. In small vial runs or kilo lots alike, consistency helps runs finish on time and analysts spend less time chasing side-products.
When manufacturers cut corners, telltale signs show up during workup and isolation: odd off-white shades, unexpected signals in NMR, or yields that suddenly fall apart. Our workflow avoids these headaches—years of checking column outcomes, troubleshooting crystallization, and logging unexpected deviations have forced us to tune our process far beyond simple technical compliance. Looking back at past competitor samples, we’ve seen issues with off-stoichiometry, bromide impurities, and volatile by-products that don’t always show up on certificates but can sabotage multi-step syntheses. We started referencing both classical TLC and modern HPLC for every batch, especially since scale-up partners have shorter timelines and less patience for surprises. At every step, we measure against the yardstick of our own best runs, not just technical minimums.
Manufacturing starts by understanding the tightrope between cost pressures and the technical needs of end-users. Electronic-grade solvents, precise pH control, and slow addition of reagents may add time, but shaving minutes at this stage creates hours of clean-up later. Some customers have reported that lower-tier suppliers offer lower sticker prices, only to introduce bottlenecks in downstream processes. For us, the calculation is basic: a clean product the first time leaves less residue, saves troubleshooting, and keeps reorders coming. That’s not just a theory—we’ve run reactions with competitor samples and seen column flows slow, filtration clogs, or unexplained residual peaks on LC-MS. These interruptions add up to lost confidence.
Regularly speaking with users, from discovery chemists to process engineers, has influenced how we monitor trace metal content, residual solvents, and halide content. For sensitive pharmaceutical applications, we have run ICP-MS checks for trace palladium or copper, and maintain documentation that lives up to customer audits. That interplay between manufacturer and end-user defines how we triage what matters—clean conversion, ease of purification, and straightforward product handling.
4-Bromo-1H-Imidazole, chemical formula C3H3BrN2, runs with a molecular weight of 146.97. In-house, we’ve watched how slight pH changes in mother liquors or small deviations in nitrogen flow shift the impurity profile. We keep our in-line monitoring tuned to spot these variations quickly. For each lot, we upload batch data to our archive, checking against baselines established with our earliest syntheses. Over many cycles, patterns emerge: careful bromination methods prevent di- or tribromination, quenching at low temperature limits hydrolysis, and slow product isolation avoids thermal decomposition.
Typical packaging solutions depend on volume—the smallest vials meet the needs of screening chemists, while sealed drums serve kilo-scale projects. Shelf stability, as many have learned, ties back to storage temperature and headspace integrity. We recommend storing at 2-8°C, limiting exposure to moisture, and using fresh material for scale-up or high-precision applications. We’ve seen how material left open to air loses crisp melting edges and shows increased water content, with consequences for coupling outcomes. For any high-sensitivity runs, a quick melting-point or HPLC check on arrival has become standard, given the unforgiving nature of many downstream steps. These recommendations grow from the experience of replacing product and troubleshooting unexpected results firsthand, not just from reading handbooks.
The most useful feedback never comes from glossy reviews or generic testimonials. A process chemist once reached out describing an unexpected tar formation during deprotonation. By tracing back both the reaction specifics and our own logs, we narrowed the culprit to a shipping delay that left product at room temperature for several summer days. In another instance, a research group found sporadic NMR shifts; performing side-by-side runs with material from two different lots isolated a single trace impurity introduced during post-reaction neutralization. Both cases reinforced the importance of batch-level documentation, and also highlighted the reality that issues rarely come from single causes but from the sum of imperfect steps. Transparency, willingness to dig into unexpected outcomes, and the humility to revisit the plant floor—these shape our approach as much as any piece of analytical equipment.
Technical teams working in pharma, biotech, or materials have different priorities: validation batches, repeat syntheses, or exploratory work. By working alongside these diverse partners, we’ve adapted our practices. Some projects require a full trace element profile, while others want rapid turnaround or help interpreting analytical noise during scale-up. We keep a buffer stock of validated lots with full supporting paperwork, ready for projects under regulatory scrutiny or facing supply bottlenecks. Over time, this partnership mindset has become our main differentiator; it helps us anticipate needs, rather than chase complaints.
Within the imidazole class, a range of brominated, chlorinated, or substituted options exist, each offering its batch of pros and cons. Running head-to-head trials, 4-Bromo-1H-Imidazole stands out for its selective reactivity: the bromine leaves as a clean handle for further coupling, with less side reaction risk compared to chloro or iodo analogues. Chlorinated imidazoles can struggle in metal-catalyzed couplings or show inconsistent yields under mild conditions, while iodinated versions raise costs and sometimes complicate downstream deprotection. For those focused on diversifying small molecule libraries, the 4-bromo variant offers balance: reactivity stays high, purification steps remain manageable, and cost stays within range even as batch sizes grow.
Some users transitioning from methyl or phenyl imidazole derivatives have reported more robust reactivity with 4-Bromo-1H-Imidazole, especially under cross-coupling conditions. The electron-withdrawing effect of bromine on the imidazole ring stabilizes certain intermediates, leading to improved yields and reduced by-products during Suzuki and Stille reactions. This feature has proven invaluable during rapid analog generation, or when moving from bench to pilot plant under tight deadlines.
Managing chemical production comes down to sweating the details. In multi-step syntheses, every gram of impurity or miscalibrated process parameter can magnify issues at scale: unexpected tarring, failed crystallizations, lost time for analytical corrections. We record every deviation, asking not why it happened in the lab, but how to prevent it miles upstream—through better raw materials, improved controls, or tighter environmental checks. Direct access to our production team, and a willingness to review not just certificates but underlying process conditions, lets customers sidestep the unseen headaches that come from loosely controlled outsourcing.
On more occasions than we can count, generic or reseller-grade material—often lacking upstream process transparency—has thrown project timelines into confusion. Shortcuts hidden behind “meets specification” badges have led to blocked reactors or poor reproducibility, which soak up far more value in lost time than any short-term savings ever repay. By operating as both manufacturer and problem-solver, we maintain not only tighter specs but also a readiness to field questions outside the tidy confines of technical data sheets. Real-world manufacturing never stays static; lessons learned in one lot inform changes and improvements for the next.
Modern research environments direct their scrutiny beyond only purity or color. Sophisticated users examine NMR, LC-MS, IR, and trace elemental analyses, digging for hidden risks. Our in-process controls spot check for these elements at each turn: verifying major and minor peaks by 1H NMR and LC, running GC-MS for trace organics, and pairing these with classic melting point and solubility checks. In instances where a client’s method spots something our default panel misses, we work backwards—running comparative checks, supplementing with impurity standards, and documenting the findings. In our experience, open exchange beats bureaucratic rigidity; long-term trust grows from putting data on the table, not hiding behind form letters.
Some applications, such as those heading into cGMP or regulated environments, require a deeper dive into trace contaminants and process reproducibility. We support these partners by maintaining chain-of-custody logs, offering full analytical transparency, and ensuring secondary confirmation of sensitive data. Rather than seeing such demands as extra work, we recognize each audit as a chance to sharpen our own controls and catch the unseen. These users challenge us to raise our own standards and, in turn, deliver value to others along the chain who rely on reproducible outcomes.
Over years in the business, returns and support tickets teach sharper lessons than any textbook. Most repeat issues stem not from base chemical faults, but from process handling mismatches: how people store material, re-dissolve it, or combine it with other solids. As the direct producer, we can circulate feedback quickly and implement small optimizations that save downstream headaches—be it switching packaging for moisture sensitivity, or offering small-lot pre-weighed aliquots for those with glovebox setups. Keeping sample archives from every batch, along with storage condition notes, lets us tackle issues retrospectively when customers return months later with questions or analysis requests.
Other producers have come and gone, especially as prices tighten and supply chain shocks ripple through the sector. The difference shows up in product quality, openness to scrutiny, and longevity in relationships. We have seen how working with clients through process improvement or deviation resolution wins more long-term loyalty than flash-in-the-pan price drops. Our commitment revolves around the cycle of improvement: each lot, each complaint, and each technical win feeds new safeguards into our workflow.
Producing chemicals like 4-Bromo-1H-Imidazole calls on more than just pushing material out the door. The true test runs through repeat projects, troubleshooting odd corners, and seeing the impact of each adjustment from upstream synthesis to end-user results. Instead of focusing on aspirational slogans, we take lessons from product returns, real-time user conversations, and tight-loop feedback after scale-up trials. Each customer gains more than a drum or bottle; they receive the assurance that real-world chemists, in the business every day, keep their needs uppermost and are ready to adapt as projects evolve. Experience compounds—every synthesis, every analysis, every phone call shapes better product and deeper trust going forward.